Observational studyBMC pregnancy and childbirth2026
Association between postcesarean delivery inpatient opioid consumption & post-discharge opioid usage: a prospective observational study.
Observational study in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe United States continues to experience increasing morbidity and mortality from opioid misuse with prescription opioids. Prescription opioids account for 32% of opioid related deaths. Cesarean delivery is the most common surgery among females. This makes this patient population directly at risk for opioid misuse as 75% of opioid prescriptions are filled after a cesarean delivery. Creating a plan for optimizing postpartum opioid pain control while limiting narcotic usage is a must. Primary objective was to identify an association of inpatient opioid use and post-discharge opioid consumption after cesarean delivery (CD).
methodsThis prospective, observational study at a single academic tertiary hospital included patients undergoing CD between February to October of 2021. 142 patients met inclusion criteria with 110 (77%) patients completing the follow up phone call. Post-CD inpatient opioid consumption, discharge opioid prescription amount, and sociodemographics were recorded from the electronic medical record. Women with opioid use disorder, wound complication, peripartum hysterectomy, general anesthesia for delivery, or readmission for infection or surgery were excluded. Patients were then contacted by phone approximately two weeks post-discharge to assess the status of their opioid tablets and their subjective pain control. Opioid amounts were recorded as Oxycodone 5 milligram (mg) tablets. Primary outcome was the association between inpatient opioid use and post-discharge opioid consumption. Secondary outcomes included disposition of tablets at two weeks post-discharge. Outcomes were analyzed using multivariable logistic regression between quartiles of inpatient and post-discharge opioid consumption.
resultsAfter CD, inpatient opioid use predicted outpatient opioid use (r
conclusionThe amount of tablets consumed post-CD as an inpatient is predictive of outpatient opioid consumption with minimal disposal of unused opioid tablets at two weeks post-discharge.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.